Human L3MBTL3 is mutated in medulloblastoma and is further implicated in other pathological disorders such as multiple sclerosis, insulin resistance, prostate cancer, and breast cancer49,53–56. The gene discussed is L3MBTL3; the disease is prostate carcinoma.